In vivo Nanoplatforms for Diagnostics (IVN:Dx)

Post Date

March 15th 2012

Application Due Date

June 28th 2012

Funding Opportunity Number

DARPA-BAA-12-33

CFDA Number(s)

12.910

Funding Instrument Type(s)

Cooperative Agreement
Grant
Other

Funding Activity Categories

Science and Technology and other Research and Development

Eligibility Categories

Unrestricted

Funding

• Award Range:

  $0 - $0

Grant Description

The specific objective of the In vivo Nanoplatforms for Diagnostics (IVN:Dx) thrust of the In vivo Nanoplatforms (IVN) program is to develop biocompatible nanosensors that provide continuous, noninvasive, and highly accurate measurement of a variety of conditions and substances within the living tissue of animals, plants, and insects using non-toxic materials with limited immunogenicity. These sensors will permit qualitative and quantitative assessment over large concentration ranges of both small (e.g., glucose, lactate, and urea) and large molecules (e.g., proteins, oligonucleotides, infectious agents, and chemical/biological threat agents) in the organism and environment through optical, electronic, thermal or magnetic mechanisms. See full DARPA-BAA-12-33 attached.

Contact Information

• Agency

  Department of Defense

• Office:

  Defense Advanced Research Projects Agency

• Agency Contact:

  Dr. Timothy Broderick
  Program Manager

• Agency Mailing Address:

  MTO BAA Coordinator

• Agency Email Address:

  DARPA-BAA-12-33@darpa.mil

• Location:

  DARPA - MTO - BAA0718

• More Information:

  MTO Solicitations Page